| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/NDT/GFX317 |
| P698 | PubMed publication ID | 29165602 |
| P50 | author | Hideki Yokoi | Q43164915 |
| P2093 | author name string | Motoko Yanagita | |
| Masashi Mukoyama | |||
| Masato Kasahara | |||
| Akira Ishii | |||
| Kenichi Koga | |||
| Kiyoshi Mori | |||
| Naohiro Toda | |||
| Keita P Mori | |||
| Keisuke Osaki | |||
| P2860 | cites work | Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis | Q39937543 |
| MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy | Q40848218 | ||
| Expression of connective tissue growth factor in experimental rat and human liver fibrosis | Q40926848 | ||
| Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice | Q41105742 | ||
| Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate | Q43218263 | ||
| Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity | Q43586378 | ||
| Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients | Q44132723 | ||
| Blocking adenosine A2A receptor reduces peritoneal fibrosis in two independent experimental models. | Q44147553 | ||
| Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model | Q44364802 | ||
| Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis | Q47578416 | ||
| FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis. | Q52984415 | ||
| Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. | Q54792706 | ||
| Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development | Q24616861 | ||
| Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure | Q27347280 | ||
| CCN2 is required for bleomycin‐induced skin fibrosis in mice | Q28295283 | ||
| Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis | Q28586397 | ||
| Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis | Q33906324 | ||
| Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor. | Q34482573 | ||
| Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury | Q34568791 | ||
| Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage | Q35210203 | ||
| CCN proteins: multifunctional signalling regulators | Q35629272 | ||
| Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis | Q35798426 | ||
| Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis | Q36104878 | ||
| LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation | Q36788697 | ||
| Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations | Q36921222 | ||
| Pathogenesis and treatment of peritoneal membrane failure | Q36949948 | ||
| TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis | Q37202739 | ||
| Crucial Role of Mesangial Cell-derived Connective Tissue Growth Factor in a Mouse Model of Anti-Glomerular Basement Membrane Glomerulonephritis. | Q37638074 | ||
| Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis. | Q38087161 | ||
| Peritoneal dialysis and inflammation. | Q38170893 | ||
| Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains | Q38343320 | ||
| Preventing peritoneal membrane fibrosis in peritoneal dialysis patients | Q38855591 | ||
| Connective tissue growth factor is a positive regulator of epithelial-mesenchymal transition and promotes the adhesion with gastric cancer cells in human peritoneal mesothelial cells | Q39258011 | ||
| CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. | Q39855226 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | connective tissue | Q25615 |
| sclerosing encapsulating peritonitis | Q26805194 | ||
| P304 | page(s) | 943-953 | |
| P577 | publication date | 2017-11-17 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation | |
| P478 | volume | 33 |
| Q58798857 | CTGF in kidney fibrosis and glomerulonephritis |
| Q92757529 | Connective tissue growth factor is correlated with peritoneal lymphangiogenesis |
| Q97529188 | Hypochlorite-induced porcine model of peritoneal fibrosis through the activation of IL1β-CX3CL1-TGFβ1 signal axis |
| Q58567829 | New Functions of Classical Compounds against Orofacial Inflammatory Lesions |
| Q60935640 | Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage |
| Q92265954 | Roles of matricellular CCN2 deposited by osteocytes in osteoclastogenesis and osteoblast differentiation |
| Q58710420 | Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis |
Search more.